Discontinuation report FORTAZ
| Report ID | 130594 |
| Drug Identification Number | 02212218 |
| Brand name | FORTAZ |
| Common or Proper name | Ceftazidime |
| Company Name | GLAXOSMITHKLINE INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | CEFTAZIDIME |
| Strength(s) | 1G |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAVENOUS |
| Packaging size | All pack sizes / Tous les formats |
| ATC code | J01DD |
| ATC description | OTHER BETA-LACTAM ANTIBACTERIALS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2020-12-21 |
| Remaining supply date | 2018-09-14 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2020-12-22 | French | Compare |
| v3 | 2020-12-22 | English | Compare |
| v2 | 2020-12-22 | French | Compare |
| v1 | 2020-12-22 | English | Compare |
Showing 1 to 4 of 4